Center on Health Equity & Access
Clinical
Health Care Cost
Health Care Delivery
Insurance
Policy
Technology
Value-Based Care

Biosimilars Cardiorenalmetabolic Dermatology Gastroenterology Hematology Hepatology Immunology Infectious Disease Mental Health Neurology Obesity Oncology Ophthalmology Pulmonology Rare Disease Respiratory Rheumatology Women's Health

Free In-Person Regional Events Focused on Oncology and Population Health

Biosimilars Center on Health Equity & Access Digital Health Formulary Gene Therapy Guidelines Health Care Administration Health Care Cost Health Care Delivery Insurance Policy Population Health Product Approvals and Launches Technology Value-Based Care

All Coverage Event Coverage Interviews News

AJMC Journals Anniversary Author Forms Authors Nominate a Rising Leader Submit a Manuscript

July 2000

home / publications / issue / 2000-07-vol6-n7

Improving the Sensitivity of Cervical Cytology: What Are the Issues?

Evan R. Myers, MD, MPH

ArticleEDITORIAL

Why Are Drug Prices Lower in Canada?

John R. Graham, MBA;Michael Walker, PhD

ArticleCOMMENTARY

Comparing the Medical Expenses of Children with Medicaid and Commercial Insurance in an HMO

G. Thomas Ray, MBA;Tracy Lieu, MD, MPH;Robin M. Weinick, PhD;Joel W. Cohen, PhD;Bruce Fireman, MA;Paul Newacheck, DrPH

ArticleCOSTS OF CARE

Clinical and Cost Implications of New Technologies for Cervical Cancer Screening: The Impact of Test Sensitivity

Martha L. Hutchinson, PhD, MD;Barry M. Berger, MD;Fredric L. Farber, BS

ArticleHEALTH ECONOMICS

High-Risk Population Health Management -- Achieving Improved Patient Outcomes and Near-Term Financial Results

John P. Lynch, MD;Samuel A. Forman, MD, MBA, MPH;Sandy Graff, RN, BA;Mark C. Gunby, DO

ArticleCASE STUDY

Design and Implementation of an Inpatient Disease Management Program

Gregory S. Cooper, MD;Keith B. Armitage, MD;Bimal Ashtar, MD;Ottorino Costantini, MD;Frederick A. Creighton, MHA;Pauline Raiz, MS;Rich

ArticleDISEASE MANAGEMENT

Managing Drug Costs: The Perception of Managed Care Pharmacy Directors

Leslie M. Litton, MS, RPh;Faye A. Sisk, PhD;Michael E. Akins, PhD

ArticleMANAGED CARE ADMINISTRATION

Interactive Voice Response Systems in the Diagnosis and Management of Chronic Disease

John D. Piette, PhD

ArticleTECHNOLOGY ASSESSMENT

Mandated Managed Care for Blind and Disables Medicaid Beneficiaries in a County-Organized Health System: Implementation Challenges and Access Issues

Zeina C. Hawkinson, PhD;Janice E. Frates, PhD

ArticleACCESS TO CARE

Recent Content

Lynae Darbes, PhD

HIV Self-Testing Clinical Trial Results Prove Feasibility in Application

Galen Shearn-Nance, BS, and Johnie Rose, MD, PhD

Investigators Advocate for Ongoing Comparison of Cancer Outcomes Among MA, FFS Beneficiaries

Outside of liver fibrosis improvements, pegbelfermin also significantly improved MASH vs placebo. | Image credit: filins - stock.adobe.com

Pegbelfermin Shows Promise in Addressing Liver Fibrosis in MASH

Galen Shearn-Nance, BS

No Significant Differences Found in Breast Cancer Treatment Between MA, FFS Beneficiaries: Galen Shearn-Nance, BS

View More Recent Content

Editorial Boards

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences
AJMC®
All rights reserved.